Formulation for the oromucosal, in particular pernasal, route
AssigneeImmunotech
InventorsJacques Chauveau, Pascal Meyer, Jacques Barbet, Michel Delaage
Life of this patent
Estimating the term…
Abstract
A liquid pharmaceutical formulation for administration by the oro-mucosal route, comprising at least one non-polypeptidic active substance and less than 5% W/W of capryl caproyl macrogol glycerides, process for its preparation and it uses.
Claims20
A liquid pharmaceutical formulation for administration by the oro-mucosal route, comprising at least one non-polypeptidic active substance and less than 5% W/W of capryl caproyl macrogol glycerides.
A method of treatment comprising administering a liquid pharmaceutical composition in an amount of less than 5% W/W of capryl caproyl macrogol glyceride in said liquid pharmaceutical formulation by the oro-mucosal route.
Dependencies are inferred from the claim text.